Stocks股票 / Health Care / DXCM

Dexcom · Health Care

DXCM US listed · USD美股 · 美元

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.德康医疗公司是一家美国跨国医疗保健公司，开发、制造、生产并分销用于糖尿病管理的连续血糖监测系统。

Large cap大盘 · $30B Health Care Broken growth成长受损
$77.94
Regular quote常规时段报价
-$0.38 · -0.49%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用，现显示常规时段报价。
52w low52周低 $53.27high高 $93.94
Hold off — timing against you暂缓 — 时机不利 Downtrend — stand aside until a new cycle low forms and confirms.下跌趋势——观望，直至新的周期低点形成并确认。 As of 2026-10-26截至 2026-10-26

Company news公司新闻

The latest reporting最新报道

One story, with the reporting behind it.将同一事件汇总，保留各来源报道。

Open in Terminal在终端打开
Checking access…正在检查访问权限…
Company intelligence公司情报

The latest call, in context把最新财报放回历史脉络

A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。

Checking latest record正在检查最新记录

Live company record实时公司记录

JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。

Continue with full transcript history继续查看完整电话会历史 ↗

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗

Technicals技术面

daily bars日线数据 · 2026-10-26
Momentum (RSI 14)动量（RSI 14） 32
Depressed偏低
vs 50-day average相对50日均线 -10.2% below下方 Below trend跌破趋势
vs 200-day average相对200日均线 +4.9% above上方 Long trend up长期向上
Volatility波动率 53th percentile第53百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。

Earnings财务业绩

next report下次财报 2026-10-29
4
days to go天后公布

Estimates being cut预期下调

Beat expectations 4 quarters in a row连续 4 季度超预期

Post-earnings drift: +3.8% (20d)财报后漂移：+3.8%（20日）

+14.8% Jun 2026
+19.1% Mar 2026
+4.6% Dec 2025
+7.0% Sep 2025

EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 11.4%

Valuation估值

Roughly fair vs sector相对行业估值合理
Multiple指标DXCM Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率（历史） 35.86x 31.50 42%
P/B市净率 10.92x 3.57 11%
P/S市销率 6.43x 3.19 27%
Earnings yield盈利收益率 2.79% 2.37 57%
FCF yield自由现金流收益率 3.59% 3.88 47%
Shareholder yield股东收益率 1.67% 1.83 47%
EV/EBITDA企业价值/EBITDA 24.99x 19.32 36%
P/FCF市值/自由现金流 27.84x 23.56 38%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入 $4.7B2025
20202025
5-yr growth5年复合增速 19.3%
Earnings per share每股收益 $2.092025
20202025
5-yr growth5年复合增速 -16.2%
Free cash flow自由现金流 $1.1B2025
20202025
Gross margin毛利率
60.1%
Operating margin营业利润率
19.6%
Net margin净利率
17.9%
FCF margin自由现金流利润率
30.9%
Balance-sheet quality财务体质 7/8 Bankruptcy risk: safe zone破产风险：安全区 Return on equity股本回报率 30% Warning警示

Leverage杠杆

Net debt / EBITDA净债务/EBITDA-0.79
Current ratio流动比率1.88

Capital allocation资本配置

Stock-based comp股权薪酬$159.6M
Share count change (1y)股数变化（1年）-1.5%

Debt coming due到期债务

FY2015 10-K

In the 12-month bucket following fiscal period end 2015-12-31, it reported $2.3M due — about 100% of its disclosed principal.在财年期末 2015-12-31 之后12个月的区间内，已披露到期本金为 $2.3M，约占其披露本金的 100%。

All maturity buckets are measured from fiscal period end 2015-12-31, not from today.所有到期区间均从财年期末 2015-12-31 起算，而非从今天起算。

First 12 months after period end报告期末之后首12个月 $2.3M
Year 2第2年 not reported未披露
Year 3第3年 not reported未披露
Year 4第4年 not reported未披露
Year 5第5年 not reported未披露
After year 55年以后 not reported未披露

Cash reported at 2025-12-31: $917700000.截至 2025-12-31 披露的现金：$917700000。 Operating cash flow exceeded or equaled equipment spending over 2025-01-01 to 2025-12-31; no cash burn to measure.在 2025-01-01 至 2025-12-31 期间，经营现金流不低于设备支出，无可衡量的现金消耗。

Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。

Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。

Sources and cash-flow calculation来源与现金流计算

Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件 0001093557-16-000432, period ending报告期截至 2015-12-31, unit单位 USD. Cache acquired缓存获取时间: 2026-09-24T08:00:30.837437+00:00. 1/6 buckets reported.个区间有披露。

  • LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo — period_mismatch
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree — period_mismatch
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour — period_mismatch
  • LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive — absent
  • LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive — absent

Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001093557-26-000027 · Filed提交日期 2026-02-12.

Cache acquired缓存获取时间: 2026-09-24T08:00:30.837437+00:00 · Evaluated as of评估截至 2026-10-26.

  • Reported operating cash flow已披露经营活动现金流: $1440700000
  • Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $363500000
  • Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $1077200000

Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。

Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题 Health Care (Equal-Weight) theme — #4 of 49 themes「医疗保健（等权）」主题 — 49 个主题中第 4 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed -18.8%空头仓位变动 -18.8%
Technical技术面 DXCM daily MACD crossed downDXCM 日线MACD下穿

Options positioning期权持仓

as of last close截至上一收盘

Market makers are net short gamma — price moves may amplify做市商净持有负伽玛，价格波动可能被放大

Expected daily move预期日波动
±3.11%
Expected weekly move预期周波动
±6.96%
Gamma flip伽玛翻转位
$79
25d risk reversal25d风险逆转
4.8%

Flow:资金流向： $2M premium traded; 0% 0DTE; 8 fresh positions; P/C 2.45; ~leans bullish (direction approx)成交权利金 $2M；0DTE占0%；8个新建仓；看跌看涨比 2.45；≈偏看涨（方向近似）

Skew: greed偏斜：贪婪
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向： -$12.0M net (0 buyers, 8 sellers)-$12.0M 净值（0 买家，8 卖家）

Signal history信号历史

engine events引擎事件
NEARING A HIGH → DOWNTREND接近高点 → 下跌趋势 AVOID. Failed cycle — price broke below the low that started this cycle, which historically means the larger trend is rolling over (~80% of cases)回避。失败周期——价格跌破了启动本周期的低点，历史上这通常意味着更大的趋势正在掉头向下（约 80% 的情形）
Oct 21, 2026
DXCM daily MACD crossed downDXCM 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $80.26.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$80.26。
Oct 19, 2026
UNCONFIRMED TURN → NEARING A HIGH未确认转向 → 接近高点
TAKE PROFITS止盈
Oct 16, 2026
DXCM weekly MACD crossed downDXCM 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Oct 16, 2026
DXCM daily MACD crossed upDXCM 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $86.04.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$86.04。
Oct 12, 2026
BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 12, 2026
DXCM StochRSI turned up from oversoldDXCM StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $85.92.StochRSI重回20上方 — 下行动量趋缓的最早预警。$85.92。
Oct 7, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Oct 7, 2026
DXCM StochRSI turned up from oversoldDXCM StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $84.30.StochRSI重回20上方 — 下行动量趋缓的最早预警。$84.30。
Oct 6, 2026
BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 2, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Showing the last 15 of显示最近15条，共 142 signals条信号

Company profile公司档案

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.德康医疗公司是一家美国跨国医疗保健公司，开发、制造、生产并分销用于糖尿病管理的连续血糖监测系统。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Above market高于市场
Quality质量
Above market高于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
  • Margin compression despite revenue growth

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考，不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-10-26 · regenerated nightly每晚更新 · Generated生成于 2026-10-26 05:47 UTC · All coverage所有股票 · Analyzer分析器